COEP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Coeptis Therapeutics Holdings Inc (COEP) is not a strong buy at this moment for a beginner investor with a long-term strategy. The stock lacks positive technical signals, has no significant news or catalysts, and its financial performance shows weak fundamentals. Given the neutral sentiment from hedge funds and insiders, and the absence of recent congress trading data, holding off on this investment is advisable.
The MACD histogram is negative and contracting, RSI is neutral at 36.979, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot point (11.772) with key resistance at 12.769 and support at 10.775. Overall, the technical indicators suggest a bearish trend.
NULL identified. No news or significant trading trends from hedge funds or insiders.
Bearish technical indicators, weak financial performance, and lack of recent positive news or trading activity.
In Q3 2025, revenue remained flat YoY at 237,441. Net income improved by 58.11% YoY but remains negative at -2,739,403. EPS dropped by -33.33% YoY to -0.58, and gross margin remained negative at -24.31%. Overall, the financials indicate weak growth and profitability.
No analyst ratings or price target changes available.
